Managing the Complications of Mild Therapeutic Hypothermia in the Cardiac Arrest Patient

Managing the Complications of Mild Therapeutic Hypothermia in the Cardiac Arrest Patient
复制标题

心脏骤停患者轻度治疗性低温并发症的处理

DOI:
--
复制
发表时间:
2015
影响因子:
3.1
通讯作者:
J. Lundbye
J. Lundbye
中科院分区:
医学3区
文献类型:
--
作者:
Adam M Noyes;J. Lundbye

文献摘要

参考文献

被引文献

相似文献

轻度治疗性低温 (MTH) 用于将心脏骤停 (CA) 患者的核心体温从 34°C 降低至 32°C,以改善院内或院外 CA 复苏后的生存率和神经系统结果。尽管 MTH 的益处有所改善,但在治疗过程中仍存在潜在的不可预见的并发症。尽管不良反应是短暂的,但临床医生在治疗接受 MTH 的患者时应注意相关并发症。我们的目标是向医学界提供与接受 MTH 的 CA 幸存者的潜在并发症相关的全面信息,因为临床医生必须了解接受 MTH 的患者发生的生理变化,以及如果发生这些变化如何做好准备和处理。我们希望通过对当前文献的回顾和对我们自己经验的反思,提供如何管理这些潜在并发症的信息。
Mild therapeutic hypothermia (MTH) is used to lower the core body temperature of cardiac arrest (CA) patients to 32°C from 34°C to provide improved survival and neurologic outcomes after resuscitation from in-hospital or out-of-hospital CA. Despite the improved benefits of MTH, there are potentially unforeseen complications associated during management. Although the adverse effects are transient, the clinician should be aware of the associated complications when managing the patient receiving MTH. We aim to provide the medical community comprehensive information related to the potential complications of survivors of CA receiving MTH, as it is imperative for the clinician to understand the physiologic changes that take place in the patient receiving MTH and how to prepare for them and manage them if they do occur. We hope to provide information of how to manage these potential complications through both a review of the current literature and a reflection of our own experience.
DOI: 10.1182/blood.v83.4.885.bloodjournal834885
发表时间: 1994
期刊: Blood
影响因子: 20.3
作者:
Gerald;Roth;D. Calverley
通讯作者: Gerald;Roth;D. Calverley
DOI: 10.1016/j.amjcard.2012.02.039
发表时间: 2012-07-01
影响因子: 2.8
作者:
Dodson, John A.;Wang, Yongfei;Chaudhry, Sarwat I.;Curtis, Jeptha P.
通讯作者: Curtis, Jeptha P.